APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artificial Pancreas Devices Systems

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.

Selected research

Market Outlook & Growth Opportunities

Global Artificial Pancreas Devices Systems Market Outlook and Growth Opportunities 2026

Report ID 173967480426 December 2025199 pages

Choose your research edition.

Industry ResearchArtificial Pancreas Devices Systems Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Pancreas Devices Systems Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Artificial Pancreas Devices Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Pancreas Devices Systems Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Pancreas Devices Systems Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

Read the full market overview

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.

Medtronic monopolizes the global Artificial Pancreas Devices Systems market, holding a share about 100%.

North America is the largest market, with a share about 60%, followed by Europe, have a share about 30 percent.

In terms of product, Threshold Suspended Device Systems is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospitals

, followed by Clinics.

This report provides an overview of the global Artificial Pancreas Devices Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Pancreas Devices Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Pancreas Devices Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Pancreas Devices Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Pancreas Devices Systems Segment by Company

Medtronic

Bigfoot Biomedical

Beta Bionics

Admetsys

Insulet

Tandem Diabetes Care

Defymed

Artificial Pancreas Devices Systems Segment by Type

Threshold Suspended Device Systems

Hybrid Closed-loop APDS

Other Systems

Artificial Pancreas Devices Systems Segment by Application

Hospitals

Clinics

Artificial Pancreas Devices Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Artificial Pancreas Devices Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Artificial Pancreas Devices Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Pancreas Devices Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Pancreas Devices Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Pancreas Devices Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Pancreas Devices Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Pancreas Devices Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Pancreas Devices Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Pancreas Devices Systems industry.

Chapter 3: Detailed analysis of Artificial Pancreas Devices Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Artificial Pancreas Devices Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Artificial Pancreas Devices Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Pancreas Devices Systems Industry Trends Table 2. Artificial Pancreas Devices Systems Industry Drivers Table 3. Artificial Pancreas Devices Systems Industry Opportunities and Challenges Table 4. Artificial Pancreas Devices Systems Industry Restraints Table 5. Global Artificial Pancreas Devices Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Pancreas Devices Systems Revenue Share by Company (2021-2026) Table 7. Global Artificial Pancreas Devices Systems Sales Volume by Company (Units) & (2021-2026) Table 8. Global Artificial Pancreas Devices Systems Sales Volume Share by Company (2021-2026) Table 9. Global Artificial Pancreas Devices Systems Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Artificial Pancreas Devices Systems Company Ranking, (2024-2026) & (USD Million) Table 11. Global Artificial Pancreas Devices Systems Key Company Manufacturing Base & Headquarters Table 12. Global Artificial Pancreas Devices Systems Company, Product Type & Application Table 13. Global Artificial Pancreas Devices Systems Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Artificial Pancreas Devices Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Threshold Suspended Device Systems Table 18. Significant Companies of Hybrid Closed-loop APDS Table 19. Significant Companies of Other Systems Table 20. Global Artificial Pancreas Devices Systems Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Artificial Pancreas Devices Systems Sales Volume by Type (2021-2026) & (Units) Table 22. Global Artificial Pancreas Devices Systems Sales Volume by Type (2027-2032) & (Units) Table 23. Global Artificial Pancreas Devices Systems Sales Volume Share by Type (2021-2026) Table 24. Global Artificial Pancreas Devices Systems Sales Volume Share by Type (2027-2032) Table 25. Global Artificial Pancreas Devices Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Artificial Pancreas Devices Systems Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Artificial Pancreas Devices Systems Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Artificial Pancreas Devices Systems Sales Value Share by Type (2021-2026) Table 29. Global Artificial Pancreas Devices Systems Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Global Artificial Pancreas Devices Systems Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 33. Global Artificial Pancreas Devices Systems Sales Volume by Application (2021-2026) & (Units) Table 34. Global Artificial Pancreas Devices Systems Sales Volume by Application (2027-2032) & (Units) Table 35. Global Artificial Pancreas Devices Systems Sales Volume Share by Application (2021-2026) Table 36. Global Artificial Pancreas Devices Systems Sales Volume Share by Application (2027-2032) Table 37. Global Artificial Pancreas Devices Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Artificial Pancreas Devices Systems Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Artificial Pancreas Devices Systems Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Artificial Pancreas Devices Systems Sales Value Share by Application (2021-2026) Table 41. Global Artificial Pancreas Devices Systems Sales Value Share by Application (2027-2032) Table 42. Global Artificial Pancreas Devices Systems Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 43. Global Artificial Pancreas Devices Systems Sales by Region (2021-2026) & (Units) Table 44. Global Artificial Pancreas Devices Systems Sales Market Share by Region (2021-2026) Table 45. Global Artificial Pancreas Devices Systems Sales by Region (2027-2032) & (Units) Table 46. Global Artificial Pancreas Devices Systems Sales Market Share by Region (2027-2032) Table 47. Global Artificial Pancreas Devices Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Artificial Pancreas Devices Systems Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Artificial Pancreas Devices Systems Sales Value Share by Region (2021-2026) Table 50. Global Artificial Pancreas Devices Systems Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Artificial Pancreas Devices Systems Sales Value Share by Region (2027-2032) Table 52. Global Artificial Pancreas Devices Systems Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Artificial Pancreas Devices Systems Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Artificial Pancreas Devices Systems Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 55. Global Artificial Pancreas Devices Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Artificial Pancreas Devices Systems Sales by Country (2021-2026) & (Units) Table 57. Global Artificial Pancreas Devices Systems Sales Market Share by Country (2021-2026) Table 58. Global Artificial Pancreas Devices Systems Sales by Country (2027-2032) & (Units) Table 59. Global Artificial Pancreas Devices Systems Sales Market Share by Country (2027-2032) Table 60. Global Artificial Pancreas Devices Systems Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Artificial Pancreas Devices Systems Sales Value Market Share by Country (2021-2026) Table 62. Global Artificial Pancreas Devices Systems Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Artificial Pancreas Devices Systems Sales Value Market Share by Country (2027-2032) Table 64. Medtronic Company Information Table 65. Medtronic Business Overview Table 66. Medtronic Artificial Pancreas Devices Systems Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Medtronic Artificial Pancreas Devices Systems Product Portfolio Table 68. Medtronic Recent Development Table 69. Bigfoot Biomedical Company Information Table 70. Bigfoot Biomedical Business Overview Table 71. Bigfoot Biomedical Artificial Pancreas Devices Systems Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio Table 73. Bigfoot Biomedical Recent Development Table 74. Beta Bionics Company Information Table 75. Beta Bionics Business Overview Table 76. Beta Bionics Artificial Pancreas Devices Systems Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Beta Bionics Artificial Pancreas Devices Systems Product Portfolio Table 78. Beta Bionics Recent Development Table 79. Admetsys Company Information Table 80. Admetsys Business Overview Table 81. Admetsys Artificial Pancreas Devices Systems Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. Admetsys Artificial Pancreas Devices Systems Product Portfolio Table 83. Admetsys Recent Development Table 84. Insulet Company Information Table 85. Insulet Business Overview Table 86. Insulet Artificial Pancreas Devices Systems Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Insulet Artificial Pancreas Devices Systems Product Portfolio Table 88. Insulet Recent Development Table 89. Tandem Diabetes Care Company Information Table 90. Tandem Diabetes Care Business Overview Table 91. Tandem Diabetes Care Artificial Pancreas Devices Systems Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio Table 93. Tandem Diabetes Care Recent Development Table 94. Defymed Company Information Table 95. Defymed Business Overview Table 96. Defymed Artificial Pancreas Devices Systems Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Defymed Artificial Pancreas Devices Systems Product Portfolio Table 98. Defymed Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Artificial Pancreas Devices Systems Distributors List Table 102. Artificial Pancreas Devices Systems Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Artificial Pancreas Devices Systems Product Image Figure 2. Global Artificial Pancreas Devices Systems Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Pancreas Devices Systems Sales Value (2021-2032) & (US$ Million) Figure 4. Global Artificial Pancreas Devices Systems Sales (2021-2032) & (Units) Figure 5. Global Artificial Pancreas Devices Systems Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Artificial Pancreas Devices Systems Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Threshold Suspended Device Systems Image Figure 10. Hybrid Closed-loop APDS Image Figure 11. Other Systems Image Figure 12. Global Artificial Pancreas Devices Systems Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Artificial Pancreas Devices Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Artificial Pancreas Devices Systems Sales Volume Share by Type (2021-2032) Figure 15. Global Artificial Pancreas Devices Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Artificial Pancreas Devices Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Artificial Pancreas Devices Systems Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Global Artificial Pancreas Devices Systems Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 21. Global Artificial Pancreas Devices Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Artificial Pancreas Devices Systems Sales Volume Share by Application (2021-2032) Figure 23. Global Artificial Pancreas Devices Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Artificial Pancreas Devices Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Artificial Pancreas Devices Systems Sales Value Share by Application (2021-2032) Figure 26. Global Artificial Pancreas Devices Systems Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 27. Global Artificial Pancreas Devices Systems Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Artificial Pancreas Devices Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Artificial Pancreas Devices Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Artificial Pancreas Devices Systems Sales Value (2021-2032) & (US$ Million) Figure 31. North America Artificial Pancreas Devices Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Artificial Pancreas Devices Systems Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Artificial Pancreas Devices Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Artificial Pancreas Devices Systems Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Artificial Pancreas Devices Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Artificial Pancreas Devices Systems Sales Value (2021-2032) & (US$ Million) Figure 37. South America Artificial Pancreas Devices Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Artificial Pancreas Devices Systems Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Artificial Pancreas Devices Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Artificial Pancreas Devices Systems Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Artificial Pancreas Devices Systems Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Threshold Suspended Device Systems
  • Hybrid Closed-loop APDS
  • Other Systems
Applications
  • Hospitals
  • Clinics
Companies covered
  • Medtronic
  • Bigfoot Biomedical
  • Beta Bionics
  • Admetsys
  • Insulet
  • Tandem Diabetes Care
  • Defymed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artificial Pancreas Devices Systems Sales Value (2021-2032)
  4. 1.2.2 Global Artificial Pancreas Devices Systems Sales Volume (2021-2032)
  5. 1.2.3 Global Artificial Pancreas Devices Systems Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Artificial Pancreas Devices Systems Market Dynamics
  1. 2.1 Artificial Pancreas Devices Systems Industry Trends
  2. 2.2 Artificial Pancreas Devices Systems Industry Drivers
  3. 2.3 Artificial Pancreas Devices Systems Industry Opportunities and Challenges
  4. 2.4 Artificial Pancreas Devices Systems Industry Restraints
3 Artificial Pancreas Devices Systems Market by Company
  1. 3.1 Global Artificial Pancreas Devices Systems Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Pancreas Devices Systems Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Pancreas Devices Systems Sales Volume by Company (2021-2026)
  4. 3.4 Global Artificial Pancreas Devices Systems Average Price by Company (2021-2026)
  5. 3.5 Global Artificial Pancreas Devices Systems Company Ranking (2024-2026)
  6. 3.6 Global Artificial Pancreas Devices Systems Company Manufacturing Base and Headquarters
  7. 3.7 Global Artificial Pancreas Devices Systems Company Product Type and Application
  8. 3.8 Global Artificial Pancreas Devices Systems Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Artificial Pancreas Devices Systems Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Artificial Pancreas Devices Systems Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Artificial Pancreas Devices Systems Market by Type
  1. 4.1 Artificial Pancreas Devices Systems Type Introduction
  2. 4.1.1 Threshold Suspended Device Systems
  3. 4.1.2 Hybrid Closed-loop APDS
  4. 4.1.3 Other Systems
  5. 4.2 Global Artificial Pancreas Devices Systems Sales Volume by Type
  6. 4.2.1 Global Artificial Pancreas Devices Systems Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Artificial Pancreas Devices Systems Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Artificial Pancreas Devices Systems Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Artificial Pancreas Devices Systems Sales Value by Type
  10. 4.3.1 Global Artificial Pancreas Devices Systems Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Artificial Pancreas Devices Systems Sales Value by Type (2021-2032)
  12. 4.3.3 Global Artificial Pancreas Devices Systems Sales Value Share by Type (2021-2032)
5 Artificial Pancreas Devices Systems Market by Application
  1. 5.1 Artificial Pancreas Devices Systems Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.2 Global Artificial Pancreas Devices Systems Sales Volume by Application
  5. 5.2.1 Global Artificial Pancreas Devices Systems Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Artificial Pancreas Devices Systems Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Artificial Pancreas Devices Systems Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Artificial Pancreas Devices Systems Sales Value by Application
  9. 5.3.1 Global Artificial Pancreas Devices Systems Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Artificial Pancreas Devices Systems Sales Value by Application (2021-2032)
  11. 5.3.3 Global Artificial Pancreas Devices Systems Sales Value Share by Application (2021-2032)
6 Artificial Pancreas Devices Systems Regional Sales and Value Analysis
  1. 6.1 Global Artificial Pancreas Devices Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Pancreas Devices Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Artificial Pancreas Devices Systems Sales by Region: 2021-2026
  4. 6.2.2 Global Artificial Pancreas Devices Systems Sales by Region (2027-2032)
  5. 6.3 Global Artificial Pancreas Devices Systems Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Artificial Pancreas Devices Systems Sales Value by Region (2021-2032)
  7. 6.4.1 Global Artificial Pancreas Devices Systems Sales Value by Region: 2021-2026
  8. 6.4.2 Global Artificial Pancreas Devices Systems Sales Value by Region (2027-2032)
  9. 6.5 Global Artificial Pancreas Devices Systems Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Artificial Pancreas Devices Systems Sales Value (2021-2032)
  12. 6.6.2 North America Artificial Pancreas Devices Systems Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Artificial Pancreas Devices Systems Sales Value (2021-2032)
  15. 6.7.2 Europe Artificial Pancreas Devices Systems Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Artificial Pancreas Devices Systems Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Artificial Pancreas Devices Systems Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Artificial Pancreas Devices Systems Sales Value (2021-2032)
  21. 6.9.2 South America Artificial Pancreas Devices Systems Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Artificial Pancreas Devices Systems Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Artificial Pancreas Devices Systems Sales Value Share by Country, 2025 VS 2032
7 Artificial Pancreas Devices Systems Country-level Sales and Value Analysis
  1. 7.1 Global Artificial Pancreas Devices Systems Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Pancreas Devices Systems Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Artificial Pancreas Devices Systems Sales by Country (2021-2032)
  4. 7.3.1 Global Artificial Pancreas Devices Systems Sales by Country (2021-2026)
  5. 7.3.2 Global Artificial Pancreas Devices Systems Sales by Country (2027-2032)
  6. 7.4 Global Artificial Pancreas Devices Systems Sales Value by Country (2021-2032)
  7. 7.4.1 Global Artificial Pancreas Devices Systems Sales Value by Country (2021-2026)
  8. 7.4.2 Global Artificial Pancreas Devices Systems Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Artificial Pancreas Devices Systems Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Artificial Pancreas Devices Systems Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Artificial Pancreas Devices Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Medtronic
  2. 8.1.1 Medtronic Company Information
  3. 8.1.2 Medtronic Business Overview
  4. 8.1.3 Medtronic Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Medtronic Artificial Pancreas Devices Systems Product Portfolio
  6. 8.1.5 Medtronic Recent Developments
  7. 8.2 Bigfoot Biomedical
  8. 8.2.1 Bigfoot Biomedical Company Information
  9. 8.2.2 Bigfoot Biomedical Business Overview
  10. 8.2.3 Bigfoot Biomedical Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bigfoot Biomedical Artificial Pancreas Devices Systems Product Portfolio
  12. 8.2.5 Bigfoot Biomedical Recent Developments
  13. 8.3 Beta Bionics
  14. 8.3.1 Beta Bionics Company Information
  15. 8.3.2 Beta Bionics Business Overview
  16. 8.3.3 Beta Bionics Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Beta Bionics Artificial Pancreas Devices Systems Product Portfolio
  18. 8.3.5 Beta Bionics Recent Developments
  19. 8.4 Admetsys
  20. 8.4.1 Admetsys Company Information
  21. 8.4.2 Admetsys Business Overview
  22. 8.4.3 Admetsys Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Admetsys Artificial Pancreas Devices Systems Product Portfolio
  24. 8.4.5 Admetsys Recent Developments
  25. 8.5 Insulet
  26. 8.5.1 Insulet Company Information
  27. 8.5.2 Insulet Business Overview
  28. 8.5.3 Insulet Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Insulet Artificial Pancreas Devices Systems Product Portfolio
  30. 8.5.5 Insulet Recent Developments
  31. 8.6 Tandem Diabetes Care
  32. 8.6.1 Tandem Diabetes Care Company Information
  33. 8.6.2 Tandem Diabetes Care Business Overview
  34. 8.6.3 Tandem Diabetes Care Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tandem Diabetes Care Artificial Pancreas Devices Systems Product Portfolio
  36. 8.6.5 Tandem Diabetes Care Recent Developments
  37. 8.7 Defymed
  38. 8.7.1 Defymed Company Information
  39. 8.7.2 Defymed Business Overview
  40. 8.7.3 Defymed Artificial Pancreas Devices Systems Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Defymed Artificial Pancreas Devices Systems Product Portfolio
  42. 8.7.5 Defymed Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artificial Pancreas Devices Systems Value Chain Analysis
  2. 9.1.1 Artificial Pancreas Devices Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artificial Pancreas Devices Systems Sales Mode & Process
  6. 9.2 Artificial Pancreas Devices Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artificial Pancreas Devices Systems Distributors
  9. 9.2.3 Artificial Pancreas Devices Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst